United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 380,100 | 362,000 | 356,300 | 311,100 | 401,500 |
| Cost of Goods | 24,000 | 25,900 | 23,400 | 28,800 | 33,000 |
| Gross Profit | 356,100 | 336,100 | 332,900 | 282,300 | 368,500 |
| Operating Expenses | 135,000 | 196,500 | 166,600 | 219,600 | 185,100 |
| Operating Income | 221,100 | 140,500 | 166,700 | 63,500 | 183,400 |
| Interest Expense | 4,900 | 5,600 | 8,200 | 10,000 | 11,700 |
| Other Income | 2,800 | -1,000 | 13,100 | 14,800 | -4,800 |
| Pre-tax Income | 219,000 | 133,900 | 171,600 | 68,300 | 166,900 |
| Income Tax | 47,800 | 26,800 | 33,900 | 15,700 | 34,500 |
| Net Income Continuous | 171,200 | 107,100 | 137,700 | 52,600 | 132,400 |
| Net Income | $171,200 | $107,100 | $137,700 | $52,600 | $132,400 |
| EPS Basic Total Ops | 3.86 | 2.43 | 3.14 | 1.23 | 3.02 |
| EPS Basic Continuous Ops | 3.86 | 2.43 | 3.14 | 1.23 | 3.02 |
| EPS Diluted Total Ops | 3.84 | 2.41 | 3.12 | 1.26 | 3.01 |
| EPS Diluted Continuous Ops | 3.84 | 2.41 | 3.12 | 1.26 | 3.01 |
| EBITDA(a) | $232,900 | $153,100 | $179,100 | $76,000 | $196,100 |